Long-Term Prognosis and Causes of Death in Systemic Lupus Erythematosus

American Journal of Medicine

Volumn 119, Issue 8, 2006, Pages 700-706

  Doria, Andrea ^a   Iaccarino, Luca ^a   Ghirardello, Anna ^a   Zampieri, Sandra ^a   Arienti, Silvia ^a   Sarzi Puttini, Piercarlo ^b   Atzeni, Fabiola ^b   Piccoli, Antonio ^a   Todesco, Silvano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Environmental factors; Lupus nephritis; Mortality; Prognosis; Severe disease; Survival; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; AUTOPSY; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POPULATION MODEL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL RATE;

EID: 33746406072     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.11.034     Document Type: Article

References (42)

1. Merrel M., and Shulman L.E. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis 1 (1955) 12-32
2. Pistiner M., Wallace D.J., Nessim S., et al. Lupus erythematosus in the 1980s. a survey of 570 patients. Semin Arthritis Rheum 21 (1991) 55-64
3. Cervera R., Khamashta M.A., Font J., et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period. a comparison of early and late manifestation in a cohort of 1000 patients. Medicine 82 (2003) 299-308
4. Gripenberg M., and Helve T. Outcome of systemic lupus erythematosus. A study of 66 patients over 7 years with reference to the predictive value of anti n-DNA antibody determination. Scand J Rheumatol 20 (1991) 104-109
5. Zandman-Goddard G., and Shoenfeld Y. SLE and infections. Clin Rev Allergy Immunol 25 (2003) 29-40
6. Kang I., and Park S.H. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 15 (2003) 528-534
7. Doria A., Shoenfeld Y., Wu R., et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62 (2003) 1071-1077
8. Manger K., Kusus M., ForsterC, et al. Factors associated with coronary artery disease calcification in young female patients with lupus. Ann Rheum Dis 62 (2003) 846-850
9. Bulkley B.H., and Roberts W.C. The heart in systemic lupus erythematosus and the changes induced by corticosteroids therapy. A study of 36 necropsy study. Am J Med 58 (1975) 243-263
10. Petri M., Perez-Gutthann S., Spence D., and Hochberg M.C. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93 (1992) 513-519
11. Zonana-Nacach A., Barr S.G., Madger L.A., and Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 43 (2000) 1801-1808
12. Bernatsky S., Ramsey-Goldman R., and Clarke A. Exploring the links between systemic lupus erythematosus and cancer. Rheum Dis Clin North Am 31 (2005) 387-402
13. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum 42 (1999) 1785-1796
14. Gladman D.D., and Urowitz M.B. Prognosis, mortality and morbidity in systemic lupus erythematosus. In: Wallace D.J., and Hahn B.H. (Eds). Dubois' Lupus Erythematosus. 6th ed (2002), Lippincott Williams and Wilkins, Philadelphia 1255-1273
15. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
16. Vitali C., Bencivelli W., Isenberg D.A., et al., The European Consensus Study Group for Disease Activity in SLE. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 10 (1992) 541-547
17. Gladman D., Ginzler E., Goldsmith C., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 39 (1996) 363-369
18. Kurata N., and Tan E.M. Identification of antibodies to nuclear acid antigens by counterimmunoelectrophoresis. Arthritis Rheum 19 (1976) 574-580
19. Bunn C.C., Gharavi A.E., and Hughes G.R.V. Antibodies to extractable nuclear antigens in 173 patients with DNA binding positive SLE. an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis. J Clin Lab Immunol 8 (1982) 13-17
20. Thiagarajan P., Pengo V., and Shapiro S.S. The use of the dilute Russel Viper Venum Time for the diagnosis of lupus anticoagulants. Blood 4 (1986) 869-874
21. Gharavi A.E., Harris E.N., Asherson R.A., and Hughes G.R.V. Anticardiolipin antibodies. isotype distribution and phospholipid specificity. Ann Rheum Dis 46 (1987) 1-6
22. Dixon W.J., Brown M.B., Engelman L., and Jennrich R.I. BMDP Statistical Software Manual (1990), UCLA, Berkeley
23. Moss K.E., Ioannou Y., Sultan S.M., et al. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 61 (2002) 409-413
24. Yeap S.S., Chow S.K., Manivasagar M., et al. Mortality pattern in Malaysian systemic lupus erythematosus. Med J Malaysia 56 (2001) 308-312
25. Bellomio V., Spindler A., Lucero E., et al. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. Lupus 9 (2000) 377-381
26. Alamanos Y., Voulgari P.V., Parassava M., et al. Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21 years incidence cohort. Rheumatology 42 (2003) 1122-1123
27. Abu-Shakra M., Urowitz M.B., Gladman D.D., and Gough J. Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Causes of death. J Rheumatol 22 (1995) 1259-1264
28. Blanco F.J., Gomez-Reino J.J., de la Mata J., et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus 7 (1998) 159-163
29. Jacobsen S., Petersen J., Ullman S., et al. Mortality and causes of death in 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol 28 (1999) 75-80
30. Mok C.C., Mak A., Chu W.P., et al. Long term survival of southern Chinese patients with systemic lupus erythematosus. A prospective study of all age-groups. Medicine 84 (2005) 218-224
31. Urowitz M.B., and Gladman D.D. How to improve morbidity and mortality in systemic lupus erythematosus. Rheumatology 39 (2000) 238-244
32. Bruce I.N., Urowitz M.B., Gladman D.D., et al. Risk factors for coronary heart disease in women with systemic lupus erythematosus. the Toronto risk factor study. Arthritis Rheum 48 (2003) 3159-3167
33. Doria A., Shoenfeld Y., and Pauletto P. Premature coronary disease in systemic lupus. N Engl J Med 350 (2004) 1571-1575 [letter]
34. Doria A., Sherer Y., Meroni P.L., and Shoenfeld Y. Inflammation and accelerated atherosclerosis. basic mechanisms. Rheum Dis Clin North Am 31 (2005) 355-362
35. Bernatsky S., Clarke A., and Ramsey-Goldman R. Malignancy and systemic lupus erythematosus. Curr Rheumatol Rep 4 (2002) 351-358
36. Abu-Shakra M., Ehrenfeld M., and Shoenfeld Y. Systemic lupus erythematosus and cancer. associated or not?. Lupus 11 (2002) 137-144
37. Sandrini S., Setti G., Bossini N., and Maiorca P. Cancer after kidney transplantation. G Ital Nefrol 21 Suppl 26 (2004) S67-S73
38. Bernatsky S., Boivin J.F., Joseph L., et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum 52 (2005) 1481-1490
39. Bujàn S., Ordi-Ros J., Paredes J., et al. Contribution of the initial features of systemic lupus erythematosus to the clinical evaluation and survival of a cohort of Mediterranean patients. Ann Rheum Dis 62 (2003) 859-865
40. Kiss E., Regeczy N., and Szegedi G. Systemic lupus erythematosus survival in Hungary. Results from a single centre. Clin Exp Rheumatol 17 (1999) 171-177
41. Wallace D.J., Podell T., Weiner J., et al. Systemic lupus erythematosus-survival patterns. experience with 609 patients. JAMA 245 (1981) 934-938
42. Rosner S., Ginzler E.M., Diamond H.S., et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 25 (1982) 612-617